Annual Net Income
-$1.00 B
-$1.18 B-672.50%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual net profit is -$1.00 billion, with the most recent change of -$1.18 billion (-672.50%) on December 31, 2023.
- During the last 3 years, IRWD annual net income has fallen by -$1.11 billion (-1043.94%).
- IRWD annual net income is now -289.66% below its all-time high of $528.45 million, reached on December 31, 2021.
Performance
IRWD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$3.65 M
+$4.51 M+523.95%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly net profit is $3.65 million, with the most recent change of +$4.51 million (+523.95%) on September 30, 2024.
- Over the past year, IRWD quarterly net income has stayed the same.
- IRWD quarterly net income is now -99.07% below its all-time high of $391.30 million, reached on June 30, 2021.
Performance
IRWD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$2.46 M
-$11.68 M-126.74%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM net profit is -$2.46 million, with the most recent change of -$11.68 million (-126.74%) on September 30, 2024.
- Over the past year, IRWD TTM net income has stayed the same.
- IRWD TTM net income is now -100.46% below its all-time high of $530.28 million, reached on September 30, 2021.
Performance
IRWD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
IRWD Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -672.5% | 0.0% | 0.0% |
3 y3 years | -1043.9% | -91.2% | -100.5% |
5 y5 years | -254.9% | -91.2% | -100.5% |
IRWD Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -289.7% | at low | -92.8% | +100.3% | -100.5% | +99.8% |
5 y | 5-year | -289.7% | at low | -99.1% | +100.3% | -100.5% | +99.8% |
alltime | all time | -289.7% | at low | -99.1% | +100.3% | -100.5% | +99.8% |
Ironwood Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $3.65 M(-524.0%) | -$2.46 M(-126.7%) |
Jun 2024 | - | -$860.00 K(-79.3%) | $9.21 M(-100.9%) |
Mar 2024 | - | -$4.16 M(+282.9%) | -$1.05 B(+5.0%) |
Dec 2023 | -$1.00 B(-672.5%) | -$1.09 M(-107.1%) | -$1.00 B(+5.2%) |
Sep 2023 | - | $15.32 M(-101.4%) | -$952.28 M(+3.8%) |
Jun 2023 | - | -$1.06 B(-2423.5%) | -$917.29 M(-604.1%) |
Mar 2023 | - | $45.71 M(-6.5%) | $181.98 M(+3.9%) |
Dec 2022 | $175.06 M(-66.9%) | $48.87 M(-2.9%) | $175.06 M(+4.5%) |
Sep 2022 | - | $50.32 M(+35.7%) | $167.57 M(-3.2%) |
Jun 2022 | - | $37.08 M(-4.4%) | $173.10 M(-67.2%) |
Mar 2022 | - | $38.80 M(-6.2%) | $527.32 M(-0.2%) |
Dec 2021 | $528.45 M(+397.7%) | $41.37 M(-25.9%) | $528.45 M(-0.3%) |
Sep 2021 | - | $55.84 M(-85.7%) | $530.28 M(+4.2%) |
Jun 2021 | - | $391.30 M(+880.1%) | $508.86 M(+256.4%) |
Mar 2021 | - | $39.93 M(-7.6%) | $142.76 M(+34.5%) |
Dec 2020 | $106.18 M(+393.7%) | $43.20 M(+25.5%) | $106.18 M(-4.2%) |
Sep 2020 | - | $34.42 M(+36.6%) | $110.83 M(+14.2%) |
Jun 2020 | - | $25.20 M(+653.5%) | $97.06 M(+15.4%) |
Mar 2020 | - | $3.35 M(-93.0%) | $84.13 M(+291.2%) |
Dec 2019 | $21.50 M(-107.6%) | $47.86 M(+131.8%) | $21.50 M(-151.4%) |
Sep 2019 | - | $20.65 M(+68.1%) | -$41.85 M(-82.3%) |
Jun 2019 | - | $12.28 M(-120.7%) | -$236.84 M(-20.7%) |
Mar 2019 | - | -$59.28 M(+282.7%) | -$298.51 M(+5.7%) |
Dec 2018 | -$282.37 M(+141.5%) | -$15.49 M(-91.1%) | -$282.37 M(+10.8%) |
Sep 2018 | - | -$174.35 M(+253.1%) | -$254.79 M(+126.0%) |
Jun 2018 | - | -$49.38 M(+14.5%) | -$112.74 M(+4.8%) |
Mar 2018 | - | -$43.14 M(-457.0%) | -$107.58 M(-8.0%) |
Dec 2017 | -$116.94 M(+43.1%) | $12.09 M(-137.4%) | -$116.94 M(-18.0%) |
Sep 2017 | - | -$32.30 M(-27.0%) | -$142.53 M(-0.6%) |
Jun 2017 | - | -$44.22 M(-15.8%) | -$143.43 M(+18.6%) |
Mar 2017 | - | -$52.50 M(+288.8%) | -$120.91 M(+48.0%) |
Dec 2016 | -$81.71 M | -$13.51 M(-59.3%) | -$81.71 M(-0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | -$33.20 M(+53.0%) | -$82.24 M(-14.7%) |
Jun 2016 | - | -$21.70 M(+63.2%) | -$96.43 M(-21.4%) |
Mar 2016 | - | -$13.30 M(-5.3%) | -$122.74 M(-14.0%) |
Dec 2015 | -$142.67 M(-24.8%) | -$14.04 M(-70.4%) | -$142.67 M(-14.2%) |
Sep 2015 | - | -$47.39 M(-1.3%) | -$166.28 M(+3.4%) |
Jun 2015 | - | -$48.02 M(+44.5%) | -$160.88 M(-7.1%) |
Mar 2015 | - | -$33.22 M(-11.8%) | -$173.21 M(-8.7%) |
Dec 2014 | -$189.62 M(-30.5%) | -$37.65 M(-10.3%) | -$189.62 M(-7.0%) |
Sep 2014 | - | -$41.99 M(-30.4%) | -$203.96 M(-8.8%) |
Jun 2014 | - | -$60.36 M(+21.6%) | -$223.74 M(-2.1%) |
Mar 2014 | - | -$49.63 M(-4.5%) | -$228.54 M(-16.2%) |
Dec 2013 | -$272.81 M(+275.6%) | -$51.99 M(-15.8%) | -$272.81 M(+3.1%) |
Sep 2013 | - | -$61.77 M(-5.2%) | -$264.68 M(+70.5%) |
Jun 2013 | - | -$65.15 M(-30.6%) | -$155.27 M(+18.6%) |
Mar 2013 | - | -$93.90 M(+114.1%) | -$130.93 M(+80.3%) |
Dec 2012 | -$72.62 M(+12.0%) | -$43.85 M(-192.1%) | -$72.62 M(+103.2%) |
Sep 2012 | - | $47.63 M(-216.7%) | -$35.74 M(-65.6%) |
Jun 2012 | - | -$40.80 M(+14.6%) | -$104.01 M(+26.8%) |
Mar 2012 | - | -$35.60 M(+410.5%) | -$82.05 M(+26.5%) |
Dec 2011 | -$64.85 M(+22.4%) | -$6.97 M(-66.2%) | -$64.85 M(-6.7%) |
Sep 2011 | - | -$20.63 M(+9.5%) | -$69.53 M(+21.6%) |
Jun 2011 | - | -$18.84 M(+2.4%) | -$57.17 M(+3.1%) |
Mar 2011 | - | -$18.40 M(+57.9%) | -$55.46 M(+4.7%) |
Dec 2010 | -$52.98 M(-25.6%) | -$11.65 M(+40.9%) | -$52.98 M(-18.8%) |
Sep 2010 | - | -$8.27 M(-51.7%) | -$65.26 M(-3.9%) |
Jun 2010 | - | -$17.14 M(+7.6%) | -$67.89 M(-1.8%) |
Mar 2010 | - | -$15.92 M(-33.5%) | -$69.14 M(-2.9%) |
Dec 2009 | -$71.19 M(+32.1%) | -$23.93 M(+119.5%) | -$71.19 M(+21.7%) |
Sep 2009 | - | -$10.90 M(-40.7%) | -$58.48 M(+22.9%) |
Jun 2009 | - | -$18.39 M(+2.3%) | -$47.58 M(+63.0%) |
Mar 2009 | - | -$17.97 M(+60.0%) | -$29.20 M(+160.0%) |
Dec 2008 | -$53.87 M(+2.1%) | -$11.23 M | -$11.23 M |
Dec 2007 | -$52.75 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual net profit?
- What is the all time high annual net income for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual net income year-on-year change?
- What is Ironwood Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly net income year-on-year change?
- What is Ironwood Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM net income year-on-year change?
What is Ironwood Pharmaceuticals annual net profit?
The current annual net income of IRWD is -$1.00 B
What is the all time high annual net income for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual net profit is $528.45 M
What is Ironwood Pharmaceuticals annual net income year-on-year change?
Over the past year, IRWD annual net profit has changed by -$1.18 B (-672.50%)
What is Ironwood Pharmaceuticals quarterly net profit?
The current quarterly net income of IRWD is $3.65 M
What is the all time high quarterly net income for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly net profit is $391.30 M
What is Ironwood Pharmaceuticals quarterly net income year-on-year change?
Over the past year, IRWD quarterly net profit has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM net profit?
The current TTM net income of IRWD is -$2.46 M
What is the all time high TTM net income for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM net profit is $530.28 M
What is Ironwood Pharmaceuticals TTM net income year-on-year change?
Over the past year, IRWD TTM net profit has changed by $0.00 (0.00%)